Bronchorelaxation of the human bronchi by CFTR activators - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pulmonary Pharmacology and Therapeutics Année : 2014

Bronchorelaxation of the human bronchi by CFTR activators

Résumé

The airway functions are profoundly affected in many diseases including asthma, COPD and cystic fibrosis (CF). CF the most common lethal autosomal recessive genetic disease is caused by mutations of the CFTR (Cystic Fibrosis transmembrane Conductance Regulator) gene, which normally encodes a multifunctional and integral membrane cAMP regulated and ATP gated Cl(-) channel expressed in airway epithelial cells. Using human lung tissues obtained from patients undergoing surgery for lung cancer, we demonstrated that CFTR participates in bronchorelaxation. Using human bronchial smooth muscle cells (HBSMC), we applied iodide influx assay to analyze the CFTR-dependent ionic transport and immunofluorescence technique to localize CFTR proteins. Moreover, the relaxation was studied in isolated human bronchial segments after pre-contraction with carbachol to determine the implication of CFTR in bronchodilation. We found in HBSMC that the pharmacology and regulation of CFTR is similar to that of its epithelial counterpart both for activation (using forskolin/genistein or a benzo[c]quinolizinium derivative) and for inhibition (CFTR(inh)-172 and GPinh5a). With human bronchial rings, we observed that whatever the compound used including salbutamol, the activation of muscular CFTR leads to a bronchodilation after constriction with carbachol. Altogether, these observations revealed that CFTR in the human airways is expressed in bronchial smooth muscle cells and can be pharmacologically manipulated leading to the hypothesis that this ionic channel could contribute to bronchodilation in human.
Fichier non déposé

Dates et versions

hal-04040435 , version 1 (22-03-2023)

Identifiants

Citer

Caroline Norez, Christophe Jayle, Frédéric Becq, Clarisse Vandebrouck. Bronchorelaxation of the human bronchi by CFTR activators. Pulmonary Pharmacology and Therapeutics, 2014, 27 (1), pp.38-43. ⟨10.1016/j.pupt.2013.06.008⟩. ⟨hal-04040435⟩
42 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More